87 related articles for article (PubMed ID: 15670486)
1. [A study of the causes of poor antiviral responses in male chronic hepatitis B patients treated with recombinant interferon-alpha].
Mao QG; Liu DL; Zhang MX; Feng XR; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):24-6. PubMed ID: 15670486
[TBL] [Abstract][Full Text] [Related]
2. [Generation of neutralizing anti-interferon antibodies and factors influencing their production in chronic hepatitis B patients receiving recombinant interferon-alpha treatment].
Mao QG; Luo KX; Zhang MX; Liu D; Hou JL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1319-22. PubMed ID: 14678902
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of neutralizing anti-interferon antibodies in chronic hepatitis B patients treated with recombinant interferon-alpha].
Mao QG; Luo KX; Liu DL; Zhang MX; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):205-7. PubMed ID: 15099466
[TBL] [Abstract][Full Text] [Related]
4. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
[TBL] [Abstract][Full Text] [Related]
5. [Viral breakthrough and neutralizing anti-interferon antibody production in chronic hepatitis B patients treated with recombinant interferon-alpha].
Liu DL; Luo KX; Feng XR; Zhang MX; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):422-4. PubMed ID: 17594805
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of interferon-alpha therapy for HBeAg-negative chronic hepatitis B and its influencing factors].
Mao QG; Luo KX; Fu QF; Feng XR; Guo YB; Zhu YF; Peng J; Hou JJ
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):582-4. PubMed ID: 15504285
[TBL] [Abstract][Full Text] [Related]
7. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
8. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
9. [The influence of interferon alpha neutralizing antibodies on the therapeutic effectiveness in patients with chronic viral hepatitis].
Tong F; Tang Y; Bai J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):345-7. PubMed ID: 12759973
[TBL] [Abstract][Full Text] [Related]
10. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
11. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA
J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment.
Uzun Y; Bozkaya H; Erden E; Cinar K; Idilman R; Yurdaydin C; Uzunalimoglu O
J Gastroenterol Hepatol; 2006 Jun; 21(6):977-81. PubMed ID: 16724981
[TBL] [Abstract][Full Text] [Related]
13. [Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine].
Xu QH; Zhang XH; Xie DY; Li JG; Chong YT; Yang L; Lu WL; Gao ZL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):334-6. PubMed ID: 18322594
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of antiviral treatment on intrahepatic HBV DNA and histology in HBeAg -positive chronic hepatitis B patients].
Lu HY; Zhuang LW; Yu YY; Si CW; Zheng JJ; Chen XY; Han ZH; Chen Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):54-6. PubMed ID: 18414702
[TBL] [Abstract][Full Text] [Related]
15. [Role of neutralizing anti-interferon antibodies during interferon therapy in patients with chronic hepatitis B].
Wang YP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):304-6. PubMed ID: 20108781
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B.
Hellström U; Lindh M; Krogsgaard K; Sylvan S
J Gastroenterol Hepatol; 2008 May; 23(5):804-10. PubMed ID: 17931371
[TBL] [Abstract][Full Text] [Related]
18. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
[TBL] [Abstract][Full Text] [Related]
19. [Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients].
Zhu M; Xu B; Yao GB
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):534-6. PubMed ID: 16042894
[TBL] [Abstract][Full Text] [Related]
20. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
Sarin SK; Kumar M; Hissar S; Sharma BC
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]